ComingUp
Gallery
About
This brief details the role of the C797S mutation in osimertinib resistance for non-small cell lung cancer (NSCLC). It reviews the molecular mechanisms of EGFR TKI failure and evaluates emerging therapeutic strategies designed to bypass this resistance.
Comments (2)
skips the trans vs cis allelic context that actually drives treatment decisions
fails to differentiate cis vs trans C797S resistance mechanisms.
Related Products
Game Assessment Prep
The Only Platform To Master All 11 Hirevue Games
Smart Ideas Database
Ready-to-sell platform with hundreds of low competition business ideas
Mock Mastet
MockMaster is a free, all-in-one prep platform for JEE and NEET aspirants. It pr
Stack Interview
Practice. Code. Interview. All in one free platform.
Mocko - Realistic Mock Tests with Detailed Feedback
Mocko.ai is an AI-powered platform for language exam preparation.
Tigrice
Everything About Parrots and Birds